Clinical Trial Update: NP202 for Treatment of Post -STEMI Left Ventricular Systolic Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for NP202 in treating post-ST-elevation myocardial infarction–related left ventricular systolic dysfunction. The current trial sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Systolic Dysfunction
• St-elevation Myocardial Infarction

Drugs mentioned

• NP202

Snippet

Sponsor: Armaron Bio Pty Ltd | Conditions: ST Elevation Myocardial Infarction | Phase 2 | Status: UNKNOWN